title: Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.
abstract: BACKGROUND
  The use of adult stem cells is limited by the quality and quantity of host stem cells. It has been demonstrated that Wharton's jelly-derived mesenchymal stem cells (WJMSCs), a primitive stromal population, could integrate into ischemic cardiac tissues and significantly improve heart function. In this randomized, controlled trial, our aim was to assess the safety and efficacy of intracoronary WJMSCs in patients with ST-elevation acute myocardial infarction (AMI).
  
  
  METHODS
  In a multicenter trial, 116 patients with acute ST-elevation MI were randomly assigned to receive an intracoronary infusion of WJMSCs or placebo into the infarct artery at five to seven days after successful reperfusion therapy. The primary endpoint of safety: the incidence of adverse events (AEs) within 18 months, was monitored and quantified. The endpoint of efficacy: the absolute changes in myocardial viability and perfusion of the infarcted region from baseline to four months, global left ventricular ejection fraction (LVEF) from baseline to 18 months were measured using F-18-fluorodeoxyglucose positron emission computed tomography (F-18-FDG-PET) and 99mTc-sestamibi single-photon emission computed tomography (99mTc-SPECT), and two-dimensional echocardiography, respectively.
  
  
  RESULTS
  During 18 months follow-up, AEs rates and laboratory tests including tumor, immune, and hematologic indexes were not different between the two groups. The absolute increase in the myocardial viability (PET) and perfusion within the infarcted territory (SPECT) was significantly greater in the WJMSC group [6.9 ± 0.6 % (95 %CI, 5.7 to 8.2)] and [7.1 ± 0.8 % (95 %CI, 5.4 to 8.8) than in the placebo group [3.3 ± 0.7 % (95 %CI, 1.8 to 4.7), P <0.0001] and 3.9 ± 0.6(95 %CI, 2.8 to 5.0), P = 0.002] at four months. The absolute increase in the LVEF at 18 months in the WJMSC group was significantly greater than that in the placebo group [7.8 ± 0.9 (6.0 to approximately 9.7) vs. 2.8 ± 1.2 (0.4 to approximately 5.1), P = 0.001]. Concomitantly, the absolute decreases in LV end-systolic volumes and end-diastolic volumes at 18 months in the WJMSC group were significantly greater than those in the placebo group (P = 0.0004, P = 0.004, respectively).
  
  
  CONCLUSIONS
  Intracoronary infusion of WJMSCs is safe and effective in patients with AMI, providing clinically relevant therapy within a favorable time window. This study encourages additional clinical trials to determine whether WJMSCs may serve as a novel alternative to BMSCs for cardiac stem cell-based therapy.
  
  
  BACKGROUND
  Clinical Trials NCT01291329 (02/05/2011).
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. lianrugao668@yahoo.com.
authors.forename: Lian R
authors.initials: LR
authors.lastname: Gao
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. yuchen911@hotmail.com.
authors.forename: Yu
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. zhangningkun2004@163.com.
authors.forename: Ning K
authors.initials: NK
authors.lastname: Zhang
authors.affiliation: Department of Cardiology, the First People's Hospital of Foshan, Guangdong Province, Foshan, China. yxli@fsyyy.com.
authors.forename: Xi L
authors.initials: XL
authors.lastname: Yang
authors.affiliation: Department of Cardiology, General Hospital of Armed Police Forces, Beijing, China. lhl518@vip.sina.com.
authors.forename: Hui L
authors.initials: HL
authors.lastname: Liu
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. wzgzyhwsj@163.com.
authors.forename: Zhi G
authors.initials: ZG
authors.lastname: Wang
authors.affiliation: Department of Biostatistics, Peking University First Hospital, the Clinical Research Institute of Peking University, Beijing, China. xiaoyan.y@foxmail.com.
authors.forename: Xiao Y
authors.initials: XY
authors.lastname: Yan
authors.affiliation: Department of Age Cardiology, the General Hospital of Chinese PLA, Beijing, China. wangyuheart@yeah.net.
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. zhuzhiming6542@sina.com.
authors.forename: Zhi M
authors.initials: ZM
authors.lastname: Zhu
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. ltc909@aliyun.com.
authors.forename: Tian C
authors.initials: TC
authors.lastname: Li
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. wanglihua66666@163.com.
authors.forename: Li H
authors.initials: LH
authors.lastname: Wang
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. jjhchy@163.com.
authors.forename: Hai Y
authors.initials: HY
authors.lastname: Chen
authors.affiliation: Department of Cardiology, the General Hospital of Chinese People's Liberation Army, Beijing, China. cyundai@medmail.com.cn.
authors.forename: Yun D
authors.initials: YD
authors.lastname: Chen
authors.affiliation: Department of Cardiology, Beijing Huaxin Hospital, Beijing, China. huangchaolian@hotmail.com.
authors.forename: Chao L
authors.initials: CL
authors.lastname: Huang
authors.affiliation: Department of Cardiology, the Second Affiliated Hospital of Dalian Medical University, Liaoning Province, Dalian, China. qupeng777@aliyun.com.
authors.forename: Peng
authors.initials: P
authors.lastname: Qu
authors.affiliation: Department of Biostatistics, Peking University First Hospital, the Clinical Research Institute of Peking University, Beijing, China. yaochen@hsc.pku.edu.cn.
authors.forename: Chen
authors.initials: C
authors.lastname: Yao
authors.affiliation: Department of Cardiology, the Central Hospital of Aerospace Corporation, Beijing, China. asch369@126.com.
authors.forename: Bin
authors.initials: B
authors.lastname: Wang
authors.affiliation: Department of Cardiology, the General Hospital of Chinese People's Liberation Army, Beijing, China. chenkevin301@msn.com.
authors.forename: Guang H
authors.initials: GH
authors.lastname: Chen
authors.affiliation: Department of Cardiology, General Hospital of Huabei Oilfield, Huabei Province, Renqiu, China. zhongmingw@163.com.
authors.forename: Zhong M
authors.initials: ZM
authors.lastname: Wang
authors.affiliation: Department of Cardiology, the First People's Hospital of Foshan, Guangdong Province, Foshan, China. yannihu@126.com.
authors.forename: Zhao Y
authors.initials: ZY
authors.lastname: Xu
authors.affiliation: Department of Age Cardiology, the General Hospital of Chinese PLA, Beijing, China. doctor_r16@163.com.
authors.forename: Jing
authors.initials: J
authors.lastname: Bai
authors.affiliation: Department of Cardiology, Central Hospital of National Petroleum Corporation, Huabei Province, Langfang, China. doctorludi@163.com.
authors.forename: Di
authors.initials: D
authors.lastname: Lu
authors.affiliation: Department of Ultrasonic Diagnosis, Navy General Hospital, Beijing, China. bjyanhua@aliyun.com.
authors.forename: Yan H
authors.initials: YH
authors.lastname: Shen
authors.affiliation: Department of Nuclear Medicine, Navy General Hospital, Beijing, China. guofeng_gf84@126.com.
authors.forename: Feng
authors.initials: F
authors.lastname: Guo
authors.affiliation: Shenzhen Beike Cell Engineering Research Institute, Guangdong Province, Shenzhen, China. muyun@beike.cc.
authors.forename: Mu Y
authors.initials: MY
authors.lastname: Liu
authors.affiliation: Department of Cardiology, General Hospital of Armed Police Forces, Beijing, China. yangyongfmmu@163.com.
authors.forename: Yong
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Department of Cardiology, the Second Affiliated Hospital of Dalian Medical University, Liaoning Province, Dalian, China. yanchunding@aliyun.com.
authors.forename: Yan C
authors.initials: YC
authors.lastname: Ding
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. yangye0407@sina.com.
authors.forename: Ye
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. tianhaitao1973@sina.com.
authors.forename: Hai T
authors.initials: HT
authors.lastname: Tian
authors.affiliation: Center of Cardiology, Navy General Hospital, Beijing, China. dingqingai2013@163.com.
authors.forename: Qing A
authors.initials: QA
authors.lastname: Ding
authors.affiliation: Department of Cardiology, Beijing Huaxin Hospital, Beijing, China. linali2006@gmail.com.
authors.forename: Li N
authors.initials: LN
authors.lastname: Li
authors.affiliation: Department of Cardiology, Beijing Chaoyang Hospital of Capital Medical University, Beijing, China. yangxc99@gmail.coma.
authors.forename: Xin C
authors.initials: XC
authors.lastname: Yang
authors.affiliation: Shenzhen Beike Cell Engineering Research Institute, Guangdong Province, Shenzhen, China. huxiang@beike.cc.
authors.forename: Xiang
authors.initials: X
authors.lastname: Hu
mesh_terms: D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D004452:Echocardiography; D005260:Female; D006801:Humans; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome; D016277:Ventricular Function, Left; D059631:Wharton Jelly